Chardan Capital Weighs in on Metagenomi FY2025 Earnings
Metagenomi, Inc. (NASDAQ:MGX – Free Report) – Equities research analysts at Chardan Capital issued their FY2025 EPS estimates for Metagenomi in a research note issued on Monday, March 24th. Chardan Capital analyst G. Livshits expects that the company will post earnings per share of ($1.47) for the year. The consensus estimate for Metagenomi’s current full-year […]
